Burden of Mental and Substance Use Disorders - China, 1990-2019

Chao Ma; Shicheng Yu; Yueqin Huang; Zhaorui Liu; Qiqi Wang; Hongguang Chen; Tingting Zhang; Maigeng Zhou

doi:10.46234/ccdcw2020.219

Burden of Mental and Substance Use Disorders - China, 1990-2019

China CDC Wkly. 2020 Oct 9;2(41):804-809. doi: 10.46234/ccdcw2020.219.

Authors

Chao Ma¹, Shicheng Yu², Yueqin Huang¹, Zhaorui Liu¹, Qiqi Wang², Hongguang Chen¹, Tingting Zhang¹, Maigeng Zhou³

Affiliations

¹ Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, China.
² Office of Epidemiology, Chinese Center for Disease Control and Prevention, Beijing, China.
³ National Center for Chronic and Non-Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Abstract

What is already known about this topic?

Mental and substance use disorders have notable contributions to the disease burden in China.

What is added by this report?

In China, mental disorders and substance use disorders accounted for 20.29 million and 5.76 million disability-adjusted life years (DALYs) in 2019, respectively; depressive disorders were the leading cause of DALYs. For mental disorders, the numbers of DALYs increased 12.06% from 2000 to 2019 while the standardized rates declined 5.24%; for substance use disorders, both the numbers and standardized rates of DALYs decreased 8.52% and 18.52%, respectively.

What are the implications for public health practices?

Mental and substance use disorders pose a challenge to the healthcare system in China. The government should take action and decrease the associated burden of disease.

Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2020.

Grants and funding

The study was supported by the National Key Research and Development Program “Applied Study on the Data-driven Prevention and Control Strategies of the Major Chronic Disease” (2018YFC1315305).